TUBB3locvps
locvps 时间:2021-01-03 阅读:(
)
TableS1:Detailedclinico-pathologicalinformationforthePUMsAbbreviations:PM=primarymanagement,LBD=largestbasaldiameter,UH=ultrasoundheight,CBI=ciliarybodyinvolvement,EOE=extraocularextension,HPF=highpowerfields,Enuc=enucleation,PBT=protonbeamRXT,LR=localresection,N=no,Y=yes,N/A=notassessed,del=deletion,amp=amplification,M3=monosomy3*=fromaSNPdataSampleIDPUMtoMUM01PUM02(MUM03)PUMtoMUM05PUM04(MUM07)PUM05(MUM08)PUMtoMUM09PUMtoMUM10PUM08(MUM11)PUMtoMUM13PUMtoMUM17PUMtoMUM18PUM18(MUM21)AgeatPM645439696448666560675467GenderMaleMaleFemaleFemaleFemaleMaleMaleFemaleFemaleMaleMaleMaleTypeofPMEnucEnucEnucEnucEnucPBTEnucLR,EnucEnucPBTPBTEnucLBD(mm)15.
516.
618.
718.
918.
78.
716.
514.
3418.
516.
215.
2UH(mm)7.
52.
48.
389.
72.
237.
64.
33.
99.
414.
1CBINNNYNNNNYNNNEOENNNNNNNNY(Episclera)NNNEpithelioidCellsYYYYYYYYYYNRYClosedLoopsYYYYNNRYYNNRNRYMitoticCount(40HPF)516286NR10204NRNR52Chr.
3status*N/AHeterozygousdeletionsandROHN/AHeterozygousdeletionsandROHHeterozygousdeletionsandROHN/AN/AHeterozygousdeletionsandROHN/AN/AN/AHeterozygousdeletionsandROHChr.
8qstatus*N/APartialampN/AAmpAmpN/AN/AAmpN/AN/AN/AAmpTableS2:Detailedclinico-pathologicalinformationfortheMUMsAbbreviations:dia=diameter,NR=notreported,N=no,Y=yes,NA=notapplicable,del=deletion,amp=amplification,D3=disomy3,M3=monosomy3,MM=metastaticmelanoma*=fromaSNPdata**=timebetweenprimarydiagnosisandlastfollow-upSampleIDMUM01MUM03MUM05MUM07MUM08MUM09MUM10MUM11MUM13MUM17MUM18MUM21TypeofSampleLiverresectionLiverresectionLiverresectionLiverresectionLiverresectionLiverresectionLiverresectionLaparoscopicbiopsyLaparoscopicbiopsyLiverresectionLiverresectionLiverresectionLesionsize(mm)40x35x1316x15x1415x11x1037x36x6225x20x320india11x9x104india12india5x2x135x25x23NRLiverSegmentIVaVIII,IIIVIII,V,VIINRVIINANANRV,VINRCellTypeMixedMixedMixedMixedEpithelioidEpithelioidSpindleSpindleMixedMixedSpindleNRPigmentationNYYYYNNRNYYYNRChr.
3status*HeterozygousdeletionsandROHHeterozygousdeletionsandROHHeterozygousdeletionsandROHIsodisomyHeterozygousdeletionsandROHIsodisomyIsodisomyHeterozygousdeletionsandROHM3M3D3M3Chr.
8qstatus*AmpPartialampAmpAmpAmpAmpAmpAmpAmpAmpAmpAmpDeceasedYNYYYYYYYYNYCauseofDeathMM---MMMMMMMMMMMMMMMM---MMOverallSurvivalTime(years)5.
513.
4**4.
22.
72.
94.
43.
31.
98.
11.
211.
1**4.
3TableS3:Listof193geneswithCNVsidentifiedinPUM02,PUM04,PUM05,andPUM08GeneSymbolGeneSymbolGeneSymbolGeneSymbolGeneSymbolGeneSymbolGeneSymbolGeneSymbolAARSCENPTDUS2KLHDC4MBTPS1NUTF2SLC7A6TUBB3ACDCHMP1AEDC4KLHL36MC1ROSGIN1SLC7A6OSURAHPACSF3CHTF8ENKD1LCATMIR140PABPN1LSMG1P7USP10ADAD2CIRH1AESRP2LINC00304MIR1538PARD6ASNAI3VAC14AFG3L1PCLEC18AEXOSC6LINC00311MIR1972-1PDFSNAI3-AS1VILLAGRPCLEC18CFAM157CLOC100129697MIR1972-2PDPRSNORD111VPS4AANKRD11COG4FAM65ALOC100131303MIR26A1PDXDC2PSNORD111BVPS9D1APRTCOG8FAM92BLOC100287036MIR3155APFKFB3SNORD68VPS9D1-AS1ASB13COTL1FANCALOC100289580MIR3155BPIEZO1SNTB2WFDC1ATP2C2CPNE7FBXO31LOC100505942MIR4722PLA2G15SPATA2LWWP2ATP6V0D1CRISPLD2FUKLOC100506083MIR5093PLCD1SPATA33ZC3H18BANPCTCFGALNSLOC101927817MIR5189PRDM7SPG7ZCCHC14C16orf86CTRLGAS8LOC101928682MIR6773PRMT7SPIRE2ZDHHC1C16orf95CTU2GAS8-AS1LOC101928708MIR6775PSKH1ST3GAL2ZDHHC7CA5ACYB5BGFOD2LOC101928737MLYCDPSMB10TAF1CZFPM1CALML3CYBAHAS3LOC101928880MTSS1LRANBP10TANGO6ZNF276CALML3-AS1DBNDD1HSD11B2LOC102724467MVDRBM17TCF25ZNF469CALML5DDX19AHSDL1LOC339059NECAB2RLTPRTERF2ZNF778CBFA2T3DDX19BIL15RALOC399715NET1RNF166THAP11TableS4:Listof135geneswithCNVsidentifiedinallPUM-MUMpairsGeneSymbolGeneSymbolGeneSymbolGeneSymbolGeneSymbolGeneSymbolGeneSymbolGeneSymbolADAM6CYP11B2HGH1LYPD2MIR6849PUF60TMED10P1ZNF7ADCK5DENND3HSF1MAF1MIR6850PYCRLTMEM249ZNF707AGO2DGAT1JRKMAFAMIR6893RECQL4TONSLARCEEF1DKIAA0125MAFA-AS1MIR7112RHPN1TOP1MTARHGAP39EPPK1KIAA1875MAPK15MIR7641-2RHPN1-AS1TRAPPC9BAI1ETV5KIFC2MFSD3MIR937RNF5P1TSNARE1BOP1EXOSC4LINC00051MIR1268AMIR939RNU6-2TSTA3BREA2FAM83HLINC01300MIR1302-7MROH1RPL8VPS28C8orf31FAM83H-AS1LOC100133669MIR4472-1MROH5SCRIBZC3H3C8orf33FBXL6LOC100287098MIR4507MROH6SCRT1ZFP41C8orf82FOXH1LOC100288181MIR4537NAPRTSCXZNF16CCDC166GLI4LOC100507316MIR4538NRBP2SHARPINZNF250CDC42P3GMLLRRC14MIR4539OPLAHSLC39A4ZNF251CHRAC1GPAA1LRRC24MIR4664PARP10SLC45A4ZNF252PCOMMD5GPIHBP1LY6DMIR661PLECSLC52A2ZNF252P-AS1CPSF1GPR20LY6EMIR6845PPP1R16ASLURP1ZNF34CYC1GPTLY6HMIR6846PSCASPATC1ZNF517CYHR1GRINALY6KMIR6847PTK2THEM6ZNF623CYP11B1GSDMDLYNX1MIR6848PTP4A3TIGD5ZNF696TableS5:DetailedresultsofSNPanalysisandIHCforallMUMsassessedSampleGeneMUM01MUM05MUM07MUM08MUM10MUM11MUM17MUM18MUM21C-MYCCNamplificationamplificationamplificationamplificationamplificationamplificationamplificationamplificationamplificationAsCNampwAIampwAIampwAIampwAIampwAIampwAIampwAIampw/oAIampwAIIHC(nuclear)moderate50%moderate70%weak5%strong80%weak20%strong95%moderate40%moderate90%strong80%IHC(score)452727467BAP1CNunchangeddeletionunchangedunchangedunchangeddeletiondeletionunchangeddeletionAsCNAllelichomozygosityLOHAllelichomozygosityAllelichomozygosityAllelichomozygosityLOHLOHunchangedLOHIHC(nuclear)negativenegativenegativenegativenegativenegativenegativepositivenegativeAbbreviations:CN=copy-numberanalysis,AsCN=allele-specificcopy-numberanalysis,IHC=immunohistochemistry,amp=amplification,LOH=lossofheterozygosity,AI=allelicimbalanceFigureS1:OverviewofchromosomaldistributionofgeneCNVsinMUMs.
Top:Amplificationswerefoundonallidentifiedchromosomes,exceptforchr.
3.
Themostcommongeneamplificationsoccurredonchr.
8,followedbychr.
20,17,and19.
Manyamplifiedgeneswereseenin50%(6/12)orlesssampleswithinthecohort.
Bottom:Deletionswerelessfrequentandmainlyoccurredonchr.
3.
However,notmorethan8/12MUMsshowedthesamegenedeletion.
FigureS2:ComparisonofCNandAsCNanlysis.
OntheleftthechromosomaldistributionfortheCNVsidentifiedwithintheMUMsaredepictedforchr.
3.
OntherightthechromosomaldistributionfortheidentifiedAsCNwithinthecohortareshownforchr.
3.
MostlyregionswithnoamplificationordeletionbyCNanalysisshowregionsofhomozygosity(ROH)inAsCNanalysis.
.
FigureS3:VennDiagrams(VD)ofdetailedanalysisofthefivePUM-MUMpairs.
TheindividualVDsforeachpair(atthetopandbottom)revealinformationregardingthecountofalteredgenesbeinguniquetoMUM(green),uniquetoPUM(red),andaresharedbetweenbothpartnersofthepair(yellow,intersect).
VDscombiningthisinformation(middle)revealthatfortheMUMsnoCNVwassharedbymorethanthreesamples,135geneswerefoundinallfivepairs,and194CNVsweredetectedinfourPUMs.
ZJI是成立于2011年原Wordpress圈知名主机商—维翔主机,2018年9月更名为ZJI,主要提供香港、日本、美国独立服务器(自营/数据中心直营)租用及VDS、虚拟主机空间、域名注册业务。本月商家针对香港阿里云线路独立服务器提供月付立减270-400元优惠码,优惠后香港独立服务器(阿里云专线)E3或者E5 CPU,SSD硬盘,最低每月仅480元起。阿里一型CPU:Intel E5-2630L...
傲游主机商我们可能很多人并不陌生,实际上这个商家早年也就是个人主机商,传说是有几个个人投资创办的,不过能坚持到现在也算不错,毕竟有早年的用户积累正常情况上还是能延续的。如果是新服务商这几年确实不是特别容易,问到几个老牌的个人服务商很多都是早年的用户积累客户群。傲游主机目前有提供XEN和KVM架构的云服务器,不少还是亚洲CN2优化节点,目前数据中心包括中国香港、韩国、德国、荷兰和美国等多个地区的CN...
优惠码50SSDOFF 首月5折50WHTSSD 年付5折15OFF 85折优惠,可循环使用荷兰VPSCPU内存SSD带宽IPv4价格购买1核1G50G1Gbps/3TB1个$ 9.10/月链接2核2G80G1Gbps/5TB1个$ 12.70/月链接2核3G100G1Gbps/7TB1个$ 16.30/月链接3核4G150G1Gbps/10TB1个$ 18.10/月链接阿联酋VPSCPU内存SS...
locvps为你推荐
域名注册公司找家正规的中文域名注册公司网络服务器租用现在网站服务器租赁一年多少钱?深圳网站空间深圳宝安网站设计,深圳网站空间,哪里做的最好???免费网站空间申请哪个网站可以申请免费的网页空间虚拟主机管理系统什么虚拟主机管理系统支持W和linux操作系统美国免费虚拟主机美国虚拟主机怎么样?美国虚拟主机那个比较好?虚拟主机提供商虚拟主机必须与域名提供商在一家买吗?m3型虚拟主机建网站,M型虚拟主机和G型虚拟主机,选哪种好?www二级域名顶级域名,二级域名,网站域名网怎样申请域名网站?
高防服务器租用 万网域名空间 新网域名管理 cn域名个人注册 vpsio cloudstack godaddy支付宝 ev证书 网站挂马检测工具 美国十次啦服务器 seednet 工信部icp备案号 100m空间 200g硬盘 1g空间 最好的qq空间 t云 卡巴斯基免费试用版 drupal安装 根服务器 更多